XORTX Therapeutics Inc. ANU.F Stock
XORTX Therapeutics Inc. Price Chart
XORTX Therapeutics Inc. ANU.F Financial and Trading Overview
| XORTX Therapeutics Inc. stock price | 0.27 EUR |
| Previous Close | 0.6 EUR |
| Open | 0.58 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 0.56 - 0.56 EUR |
| 52 Week Range | 0.38 - 2.41 EUR |
| Volume | 1K EUR |
| Avg. Volume | 907 EUR |
| Market Cap | 10.66M EUR |
| Beta (5Y Monthly) | 0.175429 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ANU.F Valuation Measures
| Enterprise Value | 3.16M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.1150793 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.401 |
Trading Information
XORTX Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | 0.175429 |
| 52-Week Change | -53.30% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.41 EUR |
| 52 Week Low | 0.38 EUR |
| 50-Day Moving Average | 0.59 EUR |
| 200-Day Moving Average | 0.77 EUR |
ANU.F Share Statistics
| Avg. Volume (3 month) | 907 EUR |
| Avg. Daily Volume (10-Days) | 310 EUR |
| Shares Outstanding | 17.99M |
| Float | 16.41M |
| Short Ratio | N/A |
| % Held by Insiders | 3.22% |
| % Held by Institutions | 13.97% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:11.74 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -40.71% |
| Return on Equity (ttm) | -62.031% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7893947 EUR |
| Net Income Avi to Common (ttm) | -6138867 EUR |
| Diluted EPS (ttm) | -0.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.91M EUR |
| Total Cash Per Share (mrq) | 0.44 EUR |
| Total Debt (mrq) | 61.54K EUR |
| Total Debt/Equity (mrq) | 0.68 EUR |
| Current Ratio (mrq) | 13.694 |
| Book Value Per Share (mrq) | 0.504 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8825760 EUR |
| Levered Free Cash Flow (ttm) | -4071737 EUR |
Profile of XORTX Therapeutics Inc.
| Country | Germany |
| State | AB |
| City | Alberta Beach |
| Address | 3710 – 33rd Street NW |
| ZIP | T2L 2M1 |
| Phone | 403 455 7727 |
| Website | https://www.xortx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and acute kidney injury (AKI) associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. The company has a collaboration and license agreements with the Icahn School of Medicine to study the incidence of AKI and hyperuricemia in patients hospitalized with COVID-19; and with the University of Florida Research Foundation, Inc. XORTX Therapeutics Inc. is based in Alberta Beach, Canada.
Q&A For XORTX Therapeutics Inc. Stock
What is a current ANU.F stock price?
XORTX Therapeutics Inc. ANU.F stock price today per share is 0.27 EUR.
How to purchase XORTX Therapeutics Inc. stock?
You can buy ANU.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for XORTX Therapeutics Inc.?
The stock symbol or ticker of XORTX Therapeutics Inc. is ANU.F.
Which industry does the XORTX Therapeutics Inc. company belong to?
The XORTX Therapeutics Inc. industry is Biotechnology.
How many shares does XORTX Therapeutics Inc. have in circulation?
The max supply of XORTX Therapeutics Inc. shares is 2M.
What is XORTX Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
XORTX Therapeutics Inc. PE Ratio is 0.00000000 now.
What was XORTX Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
XORTX Therapeutics Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the XORTX Therapeutics Inc. company belong to?
The XORTX Therapeutics Inc. sector is Healthcare.